Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kinesin family member 24 (KIF24) is a microtubule-based motor protein in the kinesin-13 subfamily that localizes to the mother centriole and acts as a negative regulator of ciliogenesis by depolymerizing centriolar microtubules and restricting aberrant cilia formation[1][4]. KIF24 interacts with centrosomal proteins (notably CP110 and Cep97) and is essential for the dynamic assembly and disassembly of primary cilia, a process critical for proper cell cycle progression and signaling. NEK2-mediated phosphorylation activates KIF24 during the S/G2 phases, promoting cilium disassembly and preventing cilia regrowth in dividing cells, a mechanism implicated in the control of cell proliferation and, when dysregulated, in certain cancers[1][3][4]. Disease relevance is supported by genetic evidence linking KIF24 variants to frontotemporal lobar degeneration and skeletal dysplasias, manifesting features of ciliopathies and providing insight into the biological importance of centriolar and ciliary dynamics[1][4]. No drugs have been reported to target KIF24 directly.
Not applicable (no known drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin family member 24 (KIF24).